12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements in Friday's pre-market session, with Evelo Biosciences, Surface Oncology, Humanigen, Oncorus, Know Labs, and Sonnet BioTherapeutics among the gainers, while Clene, BIMI Intl Medical, Evoke Pharma, Creative Medical Tech, SCWorx, and Stereotaxis were the losers.
June 16, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evelo Biosciences shares rose 320.3% to $0.35 during Friday's pre-market session, with a market cap of $39.0 million.
Evelo Biosciences experienced a significant increase in share price during Friday's pre-market session, which will likely result in a short-term positive impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Humanigen stock increased by 26.25% to $0.2, with a market cap of $24.0 million.
Humanigen's stock price increased significantly during Friday's pre-market session, suggesting a short-term positive impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Know Labs shares moved upwards by 16.19% to $1.22, with a market cap of $59.1 million.
Know Labs' share price increased significantly during Friday's pre-market session, suggesting a short-term positive impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Oncorus shares increased by 23.32% to $0.1, with a market cap of $2.4 million.
Oncorus experienced a significant increase in share price during Friday's pre-market session, indicating a short-term positive impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Sonnet BioTherapeutics shares increased by 15.14% to $1.07, with a market value of $29.3 million.
Sonnet BioTherapeutics' share price increased significantly during Friday's pre-market session, indicating a short-term positive impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Surface Oncology shares moved upwards by 32.22% to $0.98, with a market cap of $59.4 million.
Surface Oncology's share price increased significantly during Friday's pre-market session, indicating a short-term positive impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
BIMI Intl Medical shares declined by 14.42% to $0.95, with a market cap of $4.1 million.
BIMI Intl Medical's share price declined significantly during Friday's pre-market session, indicating a short-term negative impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Creative Medical Tech stock declined by 11.65% to $5.01, with a market value of $7.0 million.
Creative Medical Tech's stock price declined significantly during Friday's pre-market session, indicating a short-term negative impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Clene stock decreased by 21.9% to $0.82 during Friday's pre-market session, with a market value of $64.2 million.
Clene's stock price decreased significantly during Friday's pre-market session, suggesting a short-term negative impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Evoke Pharma stock decreased by 12.69% to $1.45, with a market cap of $4.8 million.
Evoke Pharma's stock price decreased significantly during Friday's pre-market session, suggesting a short-term negative impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Stereotaxis shares decreased by 10.9% to $1.8, with a market cap of $145.2 million.
Stereotaxis' share price decreased significantly during Friday's pre-market session, indicating a short-term negative impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
SCWorx shares declined by 11.37% to $0.33, with a market value of $4.3 million.
SCWorx's share price declined significantly during Friday's pre-market session, suggesting a short-term negative impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100